2024 Annual Meeting | H24 - Taking Neurology Outside of the Office: Turning Advocacy into a Career Game-changer (Practice and Policy Hub)

Date Saturday 04/13/24

Time 02:30 PM - 03:30 PM MDT Add To Calendar

Location Colorado Convention Center | Lobby F

Session Format This program will be presented in-person only

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs (Practice and Policy)

Director(s) Kara Stavros, MD, FAAN, Mary R. Rensel, MD, FAAN, Eva K. Ritzl, MD, MBA, FRCP (Glasgow), FAAN

Topic(s) Practice, Policy, and Ethics

Learning Objectives Participants should be able to dentify the wide range of opportunities to engage in advocacy, available at all levels of training as well as to neurologists in different types of practicel; evaluate the unique position that neurologists hold that enables them to be effective advocates for patients as well as the profession; assess challenges and barriers to participation in advocacy; and explore the benefits of advocacy over the career-span.

CME Available 1.00 CME credit

Core Competencies Interpersonal and Communication Skills, Professionalism, Systems-based Practice

Program Level Introductory

Program Tracks Brain Health

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student, Business Administrator

Teaching Styles Audience Participation, Other

Program Materials Program Evaluations

Event Timeline
02:30 PM - 03:30 PM MDT	Discussion	Taking Neurology Outside of the Office: Turning Advocacy into a Career Game-changer Kara Stavros, MD, FAAN, Mary R. Rensel, MD, FAAN, Eva K. Ritzl, MD, MBA, FRCP (Glasgow), FAAN

Faculty Disclosures
Kara Stavros, MD, FAAN	Dr. Stavros has nothing to disclose.
Mary R. Rensel, MD, FAAN	Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Rensel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cycle Pharma. Dr. Rensel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Dr. Rensel has stock in Brain Fresh LLC . The institution of Dr. Rensel has received research support from NMSS. The institution of Dr. Rensel has received research support from Roche- Genentech .
Eva K. Ritzl, MD, MBA, FRCP (Glasgow), FAAN	Dr. Ritzl has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for several law firms. Dr. Ritzl has a non-compensated relationship as a Advocacy committee co-chair and CPT and RUC representation with ACNS that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Health Policy committee member and alternate delegate to the AMA HOD with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a AAN HOD Alternate Delegate with AAN that is relevant to AAN interests or activities. Dr. Ritzl has a non-compensated relationship as a Epic Neurosciences steering board with Epic that is relevant to AAN interests or activities.